Remdesivir in renal transplant patients with coronavirus disease 2019: An observational study

Remdesivir in renal transplant patients with coronavirus disease 2019: An observational study

Introduction: Remdesivir has shown broad-spectrum antiviral activity. This drug is approved by the Food and Drug Administration for coronavirus disease 2019 (COVID-19) management. Other than a few case series and case reports, not much information is available on its use in kidney transplant recipie...

Full description

Bibliographic Details
Main Authors: Muzamil Latief, Farhat Abbas, Mohd Iqbal, Zhahid Hassan, L Naresh Goud, Obeid Shafi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Transplantation
Subjects:
coronavirus disease 2019
kidney transplant recipient
remdesivir
Online Access:http://www.ijtonline.in/article.asp?issn=2212-0017;year=2022;volume=16;issue=2;spage=216;epage=219;aulast=Latief

Internet

http://www.ijtonline.in/article.asp?issn=2212-0017;year=2022;volume=16;issue=2;spage=216;epage=219;aulast=Latief

Similar Items